multimod therapi advanc breast carcinoma patient breast cancer diseas subgroup untreat advanc diseas demonstr distant metastas time diagnosi stage iiib MO first year patient sequenti radiotherapi chemotherapi group group manag cours induct multi-drug chemotherapi mastectomi addit chemotherapi mean follow-up recent group group month follow-up complet local diseas control rate group surviv differ group patient median surviv month year group median surviv month patient aliv month survivor overal mortal patient inflammatori breast cancer group group noninflammatori diseas surviv patient group group inflammatori noninflammatori cancer estrogen receptor nodal menopaus statu surviv data neoadjuv chemotherapi surviv patient stage iiib breast carcinoma establish progress distant metastas mastectomi import compon treatment diseas 